The purpose of this Standard and its information collection requirements is to provide protection for workers from adverse health effects associated with occupational exposure to Methylenedianiline (MDA) in General Industry. Employers must monitor worker exposures within the permissible exposure limits, provide workers with medical examinations and training, and establish and maintain worker exposure-monitoring and medical records.
US Code:
29 USC 657
Name of Law: The Occupational Safety and Health Act
US Code:
29 USC 655
Name of Law: The Occupational Safety and Health Act
US Code:
29 USC 651
Name of Law: The Occupational Safety and Health Act
The Agency is requesting an adjustment decrease in burden hours from 370 hours to 334 hours. The decrease is the result of a slight decrease in the number of impacted secondary-use plants and a reduction in workers receiving initial medical examinations, receiving exposure monitoring training, and requesting access to records. There is an overall adjustment decrease in capital costs of $3,802 (from $27,982 to $24,180) resulting from a decrease in the cost to analyze a sample of airborne MDA from $119 to $87 each. However, the cost of a medical exam increased from $187 to $207.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.